nach oben

Erschienen in:

01.08.2009 | Meta-analysis

Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes

verfasst von: J. L. Sievenpiper, C. W. C. Kendall, A. Esfahani, J. M. W. Wong, A. J. Carleton, H. Y. Jiang, R. P. Bazinet, E. Vidgen, D. J. A. Jenkins

Erschienen in: Diabetologia | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Dietary non-oil-seed pulses (chickpeas, beans, peas, lentils, etc.) are a good source of slowly digestible carbohydrate, fibre and vegetable protein and a valuable means of lowering the glycaemic-index (GI) of the diet. To assess the evidence that dietary pulses may benefit glycaemic control, we conducted a systematic review and meta-analysis of randomised controlled experimental trials investigating the effect of pulses, alone or as part of low-GI or high-fibre diets, on markers of glycaemic control in people with and without diabetes.

Methods

We searched MEDLINE, EMBASE, CINAHL, and the Cochrane Library for relevant controlled trials of ≥7 days. Two independent reviewers (A. Esfahani and J. M. W. Wong) extracted information on study design, participants, treatments and outcomes. Data were pooled using the generic inverse variance method and expressed as standardised mean differences (SMD) with 95% CIs. Heterogeneity was assessed by χ ² and quantified by I ². Meta-regression models identified independent predictors of effects.

Results

A total of 41 trials (39 reports) were included. Pulses alone (11 trials) lowered fasting blood glucose (FBG) (−0.82, 95% CI −1.36 to −0.27) and insulin (−0.49, 95% CI −0.93 to −0.04). Pulses in low-GI diets (19 trials) lowered glycosylated blood proteins (GP), measured as HbA_1c or fructosamine (−0.28, 95% CI −0.42 to −0.14). Finally, pulses in high-fibre diets (11 trials) lowered FBG (−0.32, 95% CI −0.49 to −0.15) and GP (−0.27, 95% CI −0.45 to −0.09). Inter-study heterogeneity was high and unexplained for most outcomes, with benefits modified or predicted by diabetes status, pulse type, dose, physical form, duration of follow-up, study quality, macronutrient profile of background diets, feeding control and design.

Conclusions/interpretation

Pooled analyses demonstrated that pulses, alone or in low-GI or high-fibre diets, improve markers of longer term glycaemic control in humans, with the extent of the improvements subject to significant inter-study heterogeneity. There is a need for further large, well-designed trials.

Nur mit Berechtigung zugänglich

Inzucchi SE (2002) Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA 287:360–372PubMedCrossRef

Nathan DM (2006) Thiazolidinediones for initial treatment of type 2 diabetes? N Engl J Med 355:2477–2480PubMedCrossRef

Gan D (ed) (2003) Diabetes Atlas, 2nd edn. International Diabetes Federation, Brussels

Gerstein HC, Miller ME, Byington RP et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545–2559PubMedCrossRef

Nissen SE, Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356:2457–2471PubMedCrossRef

Patel A, MacMahon S, Chalmers J et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572PubMedCrossRef

UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865CrossRef

Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M (2004) Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 25:10–16PubMedCrossRef

Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072–2077PubMedCrossRef

10.

Tormo MA, Gil-Exojo I, Romero de Tejada A, Campillo JE (2004) Hypoglycaemic and anorexigenic activities of an alpha-amylase inhibitor from white kidney beans (Phaseolus vulgaris) in Wistar rats. Br J Nutr 92:785–790PubMedCrossRef

11.

Jenkins DJ, Wolever TM, Taylor RH, Barker HM, Fielden H (1980) Exceptionally low blood glucose response to dried beans: comparison with other carbohydrate foods. BMJ 281:578–580PubMedCrossRef

12.

Jenkins DJ, Ghafari H, Wolever TM et al (1982) Relationship between rate of digestion of foods and post-prandial glycaemia. Diabetologia 22:450–455PubMedCrossRef

13.

Jenkins DJ, Wolever TM, Collier GR et al (1987) Metabolic effects of a low-glycemic-index diet. Am J Clin Nutr 46:968–975PubMed

14.

Jenkins DJ, Wolever TM, Buckley G et al (1988) Low-glycemic-index starchy foods in the diabetic diet. Am J Clin Nutr 48:248–254PubMed

15.

Collier GR, Giudici S, Kalmusky J et al (1988) Low glycaemic index starchy foods improve glucose control and lower serum cholesterol in diabetic children. Diabetes Nutr Metab 1:11–18

16.

Brand JC, Colagiuri S, Crossman S, Allen A, Roberts DC, Truswell AS (1991) Low-glycemic index foods improve long-term glycemic control in NIDDM. Diabetes Care 14:95–101PubMedCrossRef

17.

Fontvieille AM, Rizkalla SW, Penfornis A, Acosta M, Bornet FR, Slama G (1992) The use of low glycaemic index foods improves metabolic control of diabetic patients over five weeks. Diabet Med 9:444–450PubMedCrossRef

18.

Wolever TM, Jenkins DJ, Vuksan V, Jenkins AL, Wong GS, Josse RG (1992) Beneficial effect of low-glycemic index diet in overweight NIDDM subjects. Diabetes Care 15:562–564PubMedCrossRef

19.

Wolever TM, Jenkins DJ, Vuksan V et al (1992) Beneficial effect of a low glycaemic index diet in type 2 diabetes. Diabet Med 9:451–458PubMed

20.

Frost G, Wilding J, Beecham J (1994) Dietary advice based on the glycaemic index improves dietary profile and metabolic control in type 2 diabetic patients. Diabet Med 11:397–401PubMed

21.

Gilbertson HR, Brand-Miller JC, Thorburn AW, Evans S, Chondros P, Werther GA (2001) The effect of flexible low glycemic index dietary advice vs measured carbohydrate exchange diets on glycemic control in children with type 1 diabetes. Diabetes Care 24:1137–1143PubMedCrossRef

22.

Komindr S, Ingsriswang S, Lerdvuthisopon N, Boontawee A (2001) Effect of long-term intake of Asian food with different glycemic indices on diabetic control and protein conservation in type 2 diabetic patients. J Med Assoc Thai 84:85–97PubMed

23.

Bouche C, Rizkalla SW, Luo J et al (2002) Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men. Diabetes Care 25:822–828PubMedCrossRef

24.

Jimenez-Cruz A, Bacardi-Gascon M, Turnbull WH, Rosales-Garay P, Severino-Lugo I (2003) A flexible, low-glycemic index Mexican-style diet in overweight and obese subjects with type 2 diabetes improves metabolic parameters during a 6-week treatment period. Diabetes Care 26:1967–1970PubMedCrossRef

25.

Jimenez-Cruz A, Turnbull WH, Bacardi-Gascon M, Rosales-Garay P (2004) A high-fiber, moderate-glycemic-index, Mexican style diet improves dyslipidemia in individuals with type 2 diabetes. Nutr Res 24:19–27CrossRef

26.

Frost GS, Brynes AE, Bovill-Taylor C, Dornhorst A (2004) A prospective randomised trial to determine the efficacy of a low glycaemic index diet given in addition to healthy eating and weight loss advice in patients with coronary heart disease. Eur J Clin Nutr 58:121–127PubMedCrossRef

27.

Rizkalla SW, Taghrid L, Laromiguiere M et al (2004) Improved plasma glucose control, whole-body glucose utilization, and lipid profile on a low-glycemic index diet in type 2 diabetic men: a randomized controlled trial. Diabetes Care 27:1866–1872PubMedCrossRef

28.

McMillan-Price J, Petocz P, Atkinson F et al (2006) Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial. Arch Intern Med 166:1466–1475PubMedCrossRef

29.

Wang H, Yang Y, Zhang Y, Han J, Wang Z (2007) Acceptance to knowledge to food glycemic index and dietary adjustment in diabetic patients. J Clin Rehabil Tissue Eng Res 11:10701–10703

30.

Ma Y, Olendzki BC, Merriam PA et al (2008) A randomized clinical trial comparing low-glycemic index vs ADA dietary education among individuals with type 2 diabetes. Nutrition 24:45–56PubMedCrossRef

31.

Wolever TM, Gibbs AL, Mehling C et al (2008) The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein. Am J Clin Nutr 87:114–125PubMed

32.

Mann JI, De Leeuw I, Hermansen K et al (2004) Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 14:373–394PubMedCrossRef

33.

CDACPGE Committee (2008) Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 32(Suppl 1):S1–S201

34.

Bantle JP, Wylie-Rosett J, Albright AL et al (2008) Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 31(Suppl 1):S61–S78PubMed

35.

Higgins JPT, Green S (eds) (2008) Cochrane handbook for systematic reviews of interventions version 5.0.0 [updated February 2008]. The Cochrane Collaboration. Available from www.cochrane-handbook.org, accessed 24 April, 2009

36.

Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 354:1896–1900PubMedCrossRef

37.

Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N (2006) Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 59:7–10PubMedCrossRef

38.

Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A (2002) Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 31:140–149PubMedCrossRef

39.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef

40.

NIST/SEMATECH (2006) NIST/SEMATECH e-Handbook of Statistical Methods. Available from http://www.itl.nist.gov/div898/handbook/, accessed 24 April, 2009

41.

Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U (2001) Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 286:944–953PubMedCrossRef

42.

Lichtenstein AH, Appel LJ, Brands M et al (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114:82–96PubMedCrossRef

43.

Jenkins DJ, Wolever TM, Taylor RH et al (1981) Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 34:362–366PubMed

44.

Foster-Powell K, Holt SH, Brand-Miller JC (2002) International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 76:5–56PubMed

45.

Anderson JW, Story L, Sieling B, Chen WJ, Petro MS, Story J (1984) Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men. Am J Clin Nutr 40:1146–1155PubMed

46.

Wursch P, Acheson K, Koellreutter B, Jequier E (1988) Metabolic effects of instant bean and potato over 6 hours. Am J Clin Nutr 48:1418–1423PubMed

47.

Cobiac L, McArthur R, Nestel PJ (1990) Can eating baked beans lower plasma cholesterol? Eur J Clin Nutr 44:819–822PubMed

48.

Fleming SE, Shaheen SM (1988) Repeated consumption of high-fiber breakfasts: effects on postprandial glucose and insulin responses after breakfast and lunch. Am J Clin Nutr 47:859–867PubMed

49.

Fruhbeck G, Monreal I, Santidrian S (1997) Hormonal implications of the hypocholesterolemic effect of intake of field beans (Vicia faba L.) by young men with hypercholesterolemia. Am J Clin Nutr 66:1452–1460PubMed

50.

Jang Y, Lee JH, Kim OY, Park HY, Lee SY (2001) Consumption of whole grain and legume powder reduces insulin demand, lipid peroxidation, and plasma homocysteine concentrations in patients with coronary artery disease: randomized controlled clinical trial. Arterioscler Thromb Vasc Biol 21:2065–2071PubMedCrossRef

51.

Nestel P, Cehun M, Chronopoulos A (2004) Effects of long-term consumption and single meals of chickpeas on plasma glucose, insulin, and triacylglycerol concentrations. Am J Clin Nutr 79:390–395PubMed

52.

Winham DM, Hutchins AM (2007) Baked bean consumption reduces serum cholesterol in hypercholesterolemic adults. Nutr Res 27:380–386CrossRef

53.

Winham DM, Hutchins AM, Johnston CS (2007) Pinto bean consumption reduces biomarkers for heart disease risk. J Am Coll Nutr 26:243–249PubMed

54.

Pittaway JK, Ahuja KD, Robertson IK, Ball MJ (2007) Effects of a controlled diet supplemented with chickpeas on serum lipids, glucose tolerance, satiety and bowel function. J Am Coll Nutr 26:334–340PubMed

55.

Simpson HC, Simpson RW, Lousley S et al (1981) A high carbohydrate leguminous fibre diet improves all aspects of diabetic control. Lancet 1:1–5PubMedCrossRef

56.

Kinmonth AL, Angus RM, Jenkins PA, Smith MA, Baum JD (1982) Whole foods and increased dietary fibre improve blood glucose control in diabetic children. Arch Dis Child 57:187–194PubMedCrossRef

57.

Riccardi G, Rivellese A, Pacioni D, Genovese S, Mastranzo P, Mancini M (1984) Separate influence of dietary carbohydrate and fibre on the metabolic control in diabetes. Diabetologia 26:116–121PubMedCrossRef

58.

Karlstrom B, Vessby B, Asp NG, Boberg M, Lithell H, Berne C (1987) Effects of leguminous seeds in a mixed diet in non-insulin-dependent diabetic patients. Diabetes Res 5:199–205PubMed

59.

O’Dea K, Traianedes K, Ireland P et al (1989) The effects of diet differing in fat, carbohydrate, and fiber on carbohydrate and lipid metabolism in type II diabetes. J Am Diet Assoc 89:1076–1086PubMed

60.

Anderson JW, Zeigler JA, Deakins DA et al (1991) Metabolic effects of high-carbohydrate, high-fiber diets for insulin-dependent diabetic individuals. Am J Clin Nutr 54:936–943PubMed

61.

Singh RB, Rastogi V, Rastogi SS, Niaz MA, Beegom R (1996) Effect of diet and moderate exercise on central obesity and associated disturbances, myocardial infarction and mortality in patients with and without coronary artery disease. J Am Coll Nutr 15:592–601PubMed

62.

Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley LJ (2000) Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 342:1392–1398PubMedCrossRef

63.

Giacco R, Parillo M, Rivellese AA et al (2000) Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care 23:1461–1466PubMedCrossRef

64.

Hall RS, Johnson SK, Baxter AL, Ball MJ (2005) Lupin kernel fibre-enriched foods beneficially modify serum lipids in men. Eur J Clin Nutr 59:325–333PubMedCrossRef

65.

Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutten GE, Van Weel C (2005) Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev Issue 2, Art. no.: CD003639. doi:10.1002/14651858.CD003639.pub2

66.

US Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research (2008) Guidance for industry diabetes mellitus: developing drugs and therapeutic biologics for treatment and prevention (DRAFT GUIDANCE). Available from http://www.fda.gov/cder/guidance/7630dft.pdf, accessed 24 April, 2009

67.

Jenkins DJ, Wolever TM, Taylor RH et al (1980) Rate of digestion of foods and postprandial glycaemia in normal and diabetic subjects. BMJ 281:14–17PubMedCrossRef

68.

Jenkins DJ, Wolever TM, Taylor RH et al (1982) Slow release dietary carbohydrate improves second meal tolerance. Am J Clin Nutr 35:1339–1346PubMed

69.

Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470PubMedCrossRef

70.

Sievenpiper JL, Jenkins DJA, Josse RG, Leiter AL, Vuksan V (2000) Body composition does not affect the intra-subject coefficient of variation of 75 g oral glucose tolerance test (OGTT) outcome but might influence the reproducibility of diagnosis. Can J Diabetes Care 24:39–46

71.

Sievenpiper JL, Kendall CWC, Bazinet RP, Wong JM, Esfahani A, Jenkins DJA (2008) Pulses as part of high-fibre interventions for glycemic control: a meta-analysis of controlled trials. J Clin Lipidol 2:S139

72.

Sievenpiper JL, Esfahani A, Wong JM et al (2009) Effect of non-oil seed pulses on glycemic control: a meta-analysis of randomized controlled experimental trials in humans. FASEB J 23:213–217 (Abstract)

Titel: Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes
verfasst von: J. L. Sievenpiper
C. W. C. Kendall
A. Esfahani
J. M. W. Wong
A. J. Carleton
H. Y. Jiang
R. P. Bazinet
E. Vidgen
D. J. A. Jenkins
Publikationsdatum: 01.08.2009
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 8/2009
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-009-1395-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2009

Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes

Hyperglycaemia and hyperinsulinaemia: is insulin-degrading enzyme the missing link?

Reducing glycaemic variability in type 1 diabetes self-management with a continuous glucose monitoring system based on wired enzyme technology

Consensus algorithm of the American Diabetes Association and the European Association for the Study of Diabetes: some concerns

Replication study for the association of new meta-analysis-derived risk loci with susceptibility to type 2 diabetes in 6,244 Japanese individuals

In vivo imaging of murine endocrine islets of Langerhans with extended-focus optical coherence microscopy